# A Study Using Olaparib Tablets for Subjects With Advanced Solid Tumours.

> **NCT03553108** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 18 (actual)

## Conditions studied

- Malignant Solid Tumor

## Interventions

- **DRUG:** Olaparib Treatment A
- **DRUG:** Olaparib Treatment B
- **DRUG:** Olaparib Treatment C
- **DRUG:** Olaparib Treatment D

## Key facts

- **NCT ID:** NCT03553108
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-05-16
- **Primary completion:** 2019-03-12
- **Final completion:** 2020-07-01
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2020-10-01

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03553108

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03553108, "A Study Using Olaparib Tablets for Subjects With Advanced Solid Tumours.". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT03553108. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*